Regulation of myocardium β-adrenoceptors pathway in ventricular remodeling of heart failure patients

Abstract

To study the role of myocardium β-adrenoceptors pathway in ventricular remodeling of heart failure patients, β-adrenegic receptor density (B_max) and the content of cAMP were measured in the papillae of left ventricle and blood lymphocyte of 20 patients suffered from heart failure (CHF) (NYHZ classification II to III) B_max were investigated using³H-dihydroalpheolol as ligand. cAMP were assessed by competitive immunoassay. Left ventricle mass index (LVMI) were measured using echocardiogram. The results showed that the B_max and cAMP in failing myocardium significantly negatively correlated with LVMI (r=−0. 77,P < 0.01 andr=−0.46P < 0.05 respectively); the B_max of myocardium and blood lymphocyte in CHF patients with NYHA I (63 ± 12 fmol/mgpro and 514±115 fmol/10⁷ cell) significantly lowered than that of NYHA I. patients (94±20 fmol/mgpro and 702 ±138 fmol/10⁷ cell); and the B_max of myocardium and blood lymphocyte in patients with abnormal LVMI (62±12 fmol/mgpro and 516±122 fmol/10⁷ cell) decreased more significantly than that with normal LVMI patients; even in nromal LVMI patients (92±21 fmol/mgpro and 682±146 fmol/10⁷ cell), the B_max of blood lymphocyte was already decreased (P < 0.01), when comparing with controls. The intralymphocyte cAMP content sygnificantly decreased than that of controls (P < 0.05). These results indicated that B_max could reflect the severity of ventricle remodeling and the impairment of myocardium. The regulation of myocardium intracellular messenger transduction was earlier than the pathologic structural change of LV remodeling.

References

[1] VictorJ. Autocrine and paracrine mechanisms in the pathophysiology of heart failure. Am J Cardiol, 1992, 70: 4c-4c

[2] DevereuxR B, AlonsoD R, LutasE M, et al. . Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy finding. Am J Cardiol, 1986, 57: 450-450

[3] MichelM C, BeckeringhJ J, IkezonoK, et al. . Lymphocyte β₂-adrenoceptors mirror precisely β₂-adrenoceptors, but poorly β₁-adrenoceptors changes in the human heart. J Hypertens, 1986, 4(6): 215-215

[4] BroddeO-E, KretschR, IkezonoK, et al. . Human β-adrenoceptors relation between myocardial and lymphocyte β-adrenoceptor density. Science, 1986, 23: 1584-1584

[5] MaiselA S. In vivo regulation of β-adrenergic receptors on mononuclear leukocytes and heart. J Clin Invest, 1988, 82: 2038-2038

[6] BristowM R, AndersonF L, PortJ D, et al. . Differences β-adrenergen in neuroeffector mechanisms in ischemic versus idiopathic dilated cardiomyopathy. Circulation, 1991, 84: 1024-1024

[7] GilbertE M, OlsenS L, RenlundO G, et al. . β-adrenergic recepro regulation and left ventricular function in idiopathic dilated cardiomyopathy. Am JCardiol, 1993, 71: 23c-23c

[8] TanL B, BenjaminI J, ClarkW A, et al. . β₂-a-drenergic receptor desensitisation may serve a cardioprotective role. Cardiovascular Research, 1992, 26: 608-608

[9] BristowM R, KantrowitzN E, GinsburgR, et al. . β₂-adrenergic function in heart muscle disease and heart failure. J Moll cell Cardiol, 1985, 17(2): 41-41

[10] KatzA M. Cardiomyopathy of overload: a major determinant of prognosis in congestive heart failure. N Engl J Med, 1990, 322: 100-100